- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Practical risk management in early phase clinical trials ; day:19 ; month:12 ; year:2018 ; pages:1-14
European journal of clinical pharmacology ; (19.12.2018), 1-14
- Urheber
-
Coates, Simon
Täubel, Jörg
Lorch, Ulrike
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-018-02607-8
- URN
-
urn:nbn:de:101:1-2019020400142485587462
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Coates, Simon
- Täubel, Jörg
- Lorch, Ulrike
- SpringerLink (Online service)
Ähnliche Objekte (12)
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials